These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 36552870)
1. The Role of Amino Acid Metabolism of Tumor Associated Macrophages in the Development of Colorectal Cancer. Jiang M; Cui H; Liu Z; Zhou X; Zhang L; Cao L; Wang M Cells; 2022 Dec; 11(24):. PubMed ID: 36552870 [TBL] [Abstract][Full Text] [Related]
2. Gab2 promotes the growth of colorectal cancer by regulating the M2 polarization of tumor‑associated macrophages. Gao X; Long R; Qin M; Zhu W; Wei L; Dong P; Chen J; Luo J; Feng J Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 37937666 [TBL] [Abstract][Full Text] [Related]
3. CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15. Liu Y; Chen X; Xu Y; Yang T; Wang H; Wang Z; Hu Z; Chen L; Zhang Z; Wu Y J Mol Med (Berl); 2024 Jan; 102(1):81-94. PubMed ID: 37987774 [TBL] [Abstract][Full Text] [Related]
4. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer. Kim SY; Park S; Kim S; Ko J Carcinogenesis; 2024 May; 45(5):300-310. PubMed ID: 38085813 [TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099 [TBL] [Abstract][Full Text] [Related]
6. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression. Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612 [TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives. Hou S; Zhao Y; Chen J; Lin Y; Qi X J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160 [TBL] [Abstract][Full Text] [Related]
8. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling. Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013 [TBL] [Abstract][Full Text] [Related]
9. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment. Ito M; Mimura K; Nakajima S; Okayama H; Saito K; Nakajima T; Kikuchi T; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Saze Z; Kono K Cancer Immunol Immunother; 2023 Jul; 72(7):2233-2244. PubMed ID: 36869896 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer. Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303 [TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy. Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572 [TBL] [Abstract][Full Text] [Related]
12. FAM198B promotes colorectal cancer progression by regulating the polarization of tumor-associated macrophages via the SMAD2 signaling pathway. Zheng X; Chen J; Nan T; Zheng L; Lan J; Jin X; Cai Y; Liu H; Chen W Bioengineered; 2022 May; 13(5):12435-12445. PubMed ID: 35587159 [TBL] [Abstract][Full Text] [Related]
13. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. Wang H; Tian T; Zhang J Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445193 [TBL] [Abstract][Full Text] [Related]
14. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer. Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188 [TBL] [Abstract][Full Text] [Related]
15. [Research progress on tumor-associated macrophages in colorectal cancer]. Huang S; Li F; Jin D Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):940-945. PubMed ID: 37882718 [TBL] [Abstract][Full Text] [Related]
16. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression. Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093 [TBL] [Abstract][Full Text] [Related]
17. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment. Li L; Tian Y Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579 [TBL] [Abstract][Full Text] [Related]
18. EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment. Li C; Song J; Guo Z; Gong Y; Zhang T; Huang J; Cheng R; Yu X; Li Y; Chen L; Ma X; Sun Y; Wang Y; Xue L Front Immunol; 2022; 13():857808. PubMed ID: 35432300 [TBL] [Abstract][Full Text] [Related]
19. Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases. Soldani C; De Simone G; Polidoro MA; Morabito A; Franceschini B; Colombo FS; Anselmo A; Milana F; Lleo A; Torzilli G; Pastorelli R; Donadon M; Brunelli L Cancer Immunol Immunother; 2024 Mar; 73(4):63. PubMed ID: 38430255 [TBL] [Abstract][Full Text] [Related]
20. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161 [No Abstract] [Full Text] [Related] [Next] [New Search]